Patents Assigned to NITROMEGA CORP.
  • Nitro fatty acids—neuroprotection and/or inhibition of cognitive decline
    Patent number: 9308189
    Abstract: A composition for treating, ameliorating and/or preventing conditions associated with cognitive decline and/or motor neuron death comprise a fatty acid component enriched for one or more activated fatty acids and a nutraceutically acceptable excipient. A method for treating, ameliorating and/or preventing conditions associated with cognitive decline and/or motor neuron death includes administering a fatty acid component enriched for one or more activated fatty acids.
    Type: Grant
    Filed: September 19, 2013
    Date of Patent: April 12, 2016
    Assignee: NITROMEGA CORP.
    Inventor: Raymond A. Miller
  • Topical compositions containing nitro fatty acids
    Patent number: 8937194
    Abstract: Activated fatty acids, topical compositions including activated fatty acids and methods for using activated fatty acids to treat a variety of diseases.
    Type: Grant
    Filed: June 30, 2011
    Date of Patent: January 20, 2015
    Assignee: Nitromega Corp.
    Inventor: Raymond A. Miller
  • Nutraceuticals containing nitro fatty acids
    Patent number: 8933255
    Abstract: Activated fatty acids, nutraceutical compositions including activated fatty acids, methods for using activated fatty acids to treat a variety of diseases, and methods for preparing activated fatty acids are provided herein.
    Type: Grant
    Filed: December 31, 2009
    Date of Patent: January 13, 2015
    Assignee: Nitromega Corp.
    Inventor: Raymond A. Miller
  • NITRO FATTY ACIDS - NEUROPROTECTION AND/OR INHIBITION OF COGNITIVE DECLINE
    Publication number: 20140017219
    Abstract: A composition for treating, ameliorating and/or preventing conditions associated with cognitive decline and/or motor neuron death comprise a fatty acid component enriched for one or more activated fatty acids and a nutraceutically acceptable excipient. A method for treating, ameliorating and/or preventing conditions associated with cognitive decline and/or motor neuron death includes administering a fatty acid component enriched for one or more activated fatty acids.
    Type: Application
    Filed: September 19, 2013
    Publication date: January 16, 2014
    Applicant: Nitromega Corp.
    Inventor: Raymond A. Miller
  • Nitro fatty acids - neuroprotection and/or inhibition of cognitive decline
    Patent number: 8563609
    Abstract: A composition for treating, ameliorating and/or preventing conditions associated with cognitive decline and/or motor neuron death comprise a fatty acid component enriched for one or more activated fatty acids and a nutraceutically acceptable excipient. A method for treating, ameliorating and/or preventing conditions associated with cognitive decline and/or motor neuron death includes administering a fatty acid component enriched for one or more activated fatty acids.
    Type: Grant
    Filed: May 13, 2011
    Date of Patent: October 22, 2013
    Assignee: Nitromega Corp.
    Inventor: Raymond A. Miller
  • NITRO FATTY ACIDS - NEUROPROTECTION AND/OR INHIBITION OF COGNITIVE DECLINE
    Publication number: 20110280852
    Abstract: A composition for treating, ameleliorating and/or preventing conditions associated with cognitive decline and/or motor neuron death comprise a fatty acid component enriched for one or more activated fatty acids and a nutraceutically acceptable excipient. A method for treating, ameliorating and/or preventing conditions associated with cognitive decline and/or motor neuron death includes administering a fatty acid component enriched for one or more activated fatty acids.
    Type: Application
    Filed: May 13, 2011
    Publication date: November 17, 2011
    Applicant: NITROMEGA CORP.
    Inventor: Raymond A. Miller
  • TOPICAL COMPOSITIONS CONTAINING NITRO FATTY ACIDS
    Publication number: 20110256247
    Abstract: Activated fatty acids, topical compositions including activated fatty acids and methods for using activated fatty acids to treat a variety of diseases.
    Type: Application
    Filed: June 30, 2011
    Publication date: October 20, 2011
    Applicant: NITROMEGA CORP.
    Inventor: Raymond A. Miller